Source: Radient Technologies Inc.
  • Radient Technologies (RTI) has announced a non-brokered private placement for gross proceeds of up to $1,200,000
  • The company will issue up to 30 units priced at $40,000 per unit
  • The offering is scheduled to close on or about June 30, 2022
  • Radient Technologies is a commercial manufacturer of high-quality cannabinoid-based formulations, ingredients and products
  • Radient Technologies Inc. (RTI) opened trading at C$0.025 per share

Radient Technologies (RTI) has announced a non-brokered private placement for gross proceeds of up to $1,200,000.

The company will issue up to 30 units priced at $40,000 per unit. Each unit will consist of 1,000,000 common shares and 500,000 share purchase warrants. Each warrant will entitle the holder to purchase one additional common share for 36 months following the closing of the offering. Warrants are subject to an acceleration clause.

The offering is scheduled to close on or about June 30, 2022. 

Net proceeds will be used for working capital and general corporate purposes.

All securities issued will be subject to a statutory four-month hold period.

Radient Technologies is a commercial manufacturer of high-quality cannabinoid-based formulations, ingredients and products.

Radient Technologies Inc. (RTI) opened trading at C$0.025 per share.

More From The Market Online

Neurothera cannabinoid tech disarms antibiotic resistance

Neurothera Labs now holds a US patent for combining antimicrobials and cannabinoids to boost antibiotics against resistant bacterial strains.

The 5-Minute Investor Podcast, Ep. 24: Cannabis reclassification plays

Listen to episode 24 of Stockhouse's 5-Minute Investor Podcast, featuring analysis on cannabis stocks Canopy Growth and Aurora.
Cannabis Report image of farmed cannabis plants

StockTalk | Cannabis Report: Quarterly report season heats up

Vertically-integrated producer of premium-grade cannabis products, Cannara Biotech Inc. reported gross cannabis revenues before excise taxes...
Cannabis Report across cannabis plants

StockTalk | Cannabis Report: Shake-ups

MediPharm Labs announced that chief executive officer, David Pidduck will step down from his role, effective January...